Project cooperationUpdated on 15 March 2026
Infrared-Based Safe and Sustainable Technologies for Environmental Viral Inactivation
Prof. Dr. at ISTANBUL UNIVERSITY-CERRAHPASA
İstanbul, Türkiye
About
IR-SAFE develops innovative infrared (IR) technologies for safe, chemical-free inactivation of viruses on contaminated surfaces and residual droplets in indoor environments. The project harnesses controlled photothermal effects to destabilize viral particles through moderate, precisely regulated heating, offering a sustainable alternative to chemical disinfectants and UV-based systems.
Combining expertise in clinical virology, infrared engineering, and metrology, the consortium will establish scientific evidence on IR-induced viral inactivation, define safe exposure parameters, and develop smart prototype systems for real-world settings such as hospitals and public spaces. Demonstrations will evaluate performance, safety, energy efficiency, and material compatibility.
IR-SAFE aims to deliver a new class of environmentally friendly environmental disinfection solutions, strengthening Europe’s preparedness for future infectious disease outbreaks while reducing chemical use and supporting sustainable hygiene technologies.
Topic
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
Type
- Partner seeks Consortium/Coordinator
Attached files
Organisation
Similar opportunities
Project cooperation
Novel "Innate" Approaches for Vaccines in Low- and Middle-Income Countries
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
Fabrizio Chiodo
Associate Professor (Italian National Research Council) at Consiglio Nazionale delle Ricerche
Palermo, Italy
Project cooperation
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
Daniela Ogonczyk-Makowska
R&D Project Leader at Vaxinano
Loos, France
Project cooperation
Enhancing Novel Vaccine Candidate Production Yields
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
Andrea Vervoort
External Scientific Program Manager at Virica Biotech
Ottawa, Canada